/vanguard/ noun: Vanguard: A creative group active in innovation and application of new concepts & technologies in a given field.
Diagnostics is amongst the most crucial elements of healthcare delivery today and it’s imperative to ensure that it is
accessible and affordable for all those who need it the most.
Vanguard Diagnostics aims to contribute to better healthcare in India and emerging markets by developing, manufacturing & marketing high quality diagnostic products at affordable prices.
Veena Kohli
CEO / Founder
Veena Kohli is an alumnus of the All India Institute of Medical Sciences, New Delhi. She has 30+ years of experience in the domains of Medical Diagnostics, Life Sciences, Chemicals and Animal Health Care. During the course, she had the opportunity to develop rare skill and expertise encompassing the entire value chain of Product & Business, starting from R&D, Manufacturing, Quality, Supply Chain, Product Management and Technical Services to Business Management – Domestic & Global.
Global business leadership
In her earlier avatar, Ms. Kohli was the Vice President and Head of the Global Diagnostics Business Unit at Avantor Performance Materials, a US based Diagnostics and Fine Chemicals organization. She was responsible for business strategy formulation, product road map, driving business
Director Technical
Dr. Tiwari holds a doctorate degree in Biotechnology from Barkatullah University, Bhopal, MP, India and has been awarded with American, European, Indian patents and World Intellectual Property Copyright from the World Intellectual Property Organization on his PhD work on a diagnostic kit for detecting pulmonary and extra-pulmonary tuberculosis.
The fundamental research work done by Dr. Tiwari during his PhD has been appreciated and funded by the Department of Biotechnology, Ministry of Science & Technology, Govt. of India for developing the TB screen test for the detection and diagnosis of M. Tuberculosis. He has worked as a scientific advisor cum external collaborator in the above research program for the development of a diagnostic kit for early and rapid detection of pulmonary and extra-pulmonary tuberculosis and for its evaluation in health centers. He has guided more than 15 post
Director Sales
Anil Virmani is an experienced business professional with over 36 years of experience in spearheading strategies and business development. He has been a high-performing professional, meeting ambitious customer acquisitions both in the Government and Private sectors.
He has been responsible for developing and implementing business strategies to achieve organizational objectives on a sustained basis.
Anil has a special acumen for identifying, nurturing and growing key talent in the organization and commercial accounts.
Before becoming a part of the Vanguard Diagnostics, Anil had held several senior roles at Avantor Performance Materials India Ltd., RFCL & Godrej Industries Limited.
Director Sales
Rahul Thakur has a Masters in Business Administration and 16+ years of successful sales experience, consistently meeting and exceeding targets.
He has a natural and outstanding flair for effective team management and customer engagement.
Rahul has demonstrable experience in developing client-focused, differentiated and achievable solutions. He has been responsible for developing and executing key growth sales strategies, tactics and action plans required to achieve financial targets.
Rahul has successfully managed senior sales and commercial roles throughout his career.
Director Corporate Affairs
An alumnus of IIT-Delhi, Vinod Kumar holds 38 years of work experience in senior management positions with the longest at BHEL – a Maharatna company, largest engineering enterprise with a product portfolio of nearly 200 and an enviable record of profit making without a break for more than 30 years.
His areas of expertise include Corporate Affairs, Marketing and Project Development, Project Engineering, System Design and Integration, Erection & Commissioning of plants.
Currently he is CEO, Atal Incubation Centre supported by NITI Aayog, Govt of India under the Atal Innovation Mission, to support start ups in Health Tech, Agri Tech, Renewable Energy and Clean Mobility.
Our model aims at serving as the development and manufacturing arm for the non-manufacturing companies in India thereby reducing the need for import and giving an impetus to the ‘Make in India’ initiative.
With a manufacturing capacity of 1.5 million liters per annum, we are the youngest and one of the largest manufacturers of Hematology Reagents in India. Hematology is our flagship product line having capacity of 1.5 Million liters per year in a single shift and contributes to ~68% of our topline revenue.
We have been able to convert over 200 containers worth of import from China pertaining to Hematology reagents to a viable Indian solution, by providing domestically developed and manufactured products to our customers. Thus making a small contribution to the ‘Make in India’ initiative.
- Our model aims at serving as the development and manufacturing arm for the non-manufacturing companies in India thereby reducing the need for import and giving an impetus to the ‘Make in India’ initiative.
- With a manufacturing capacity of 1.5 million liters per annum, we are the youngest and one of the largest manufacturers of Hematology Reagents in India. Hematology is our flagship product line having capacity of 1.5 Million liters per year in a single shift and contributes to ~68% of our topline revenue.
- We have been able to convert over 200 containers worth of import from China pertaining to Hematology reagents to a viable Indian solution, by providing domestically developed and manufactured products to our customers. Thus making a small contribution to the ‘Make in India’ initiative.
in-vitro Diagnostics Industry today in India
in-vitro Diagnostics (IVD) is a part of the healthcare industry with a market size of ~$1.3 Bn. The Indian IVD industry is estimated to have recorded a year-on-year growth of more than 30% during the calendar year 2020, which is close to double the rate at which the industry had grown in the past decade. This is attributable primarily to an unprecedented surge in the demand for Covid -19 related products during this period.
Additionally, the disease burden of India has come to resemble that of the West, with more and more Indians suffering from lifestyle related diseases like Diabetes mellitus, Cardiovascular disease and Cancer. It is seven times more expensive to diagnose, treat or monitor a lifestyle related disease as compared to an infectious disease. Hematology, Clinical Chemistry and Immunology segments constitute more than 80% of the total diagnostics market.
in-vitro Diagnostics (IVD) is a part of the healthcare industry with a market size of ~$1.3 Bn. The Indian IVD industry is estimated to have recorded a year-on-year growth of more than 30% during the calendar year 2020, which is close to double the rate at which the industry had grown in the past decade. This is attributable primarily to an unprecedented surge in the demand for Covid -19 related products during this period.
Additionally, the disease burden of India has come to resemble that of the West, with more and more Indians suffering from lifestyle related diseases like Diabetes mellitus, Cardiovascular disease and Cancer. It is seven times more expensive to diagnose, treat or monitor a lifestyle related disease as compared to an infectious disease. Hematology, Clinical Chemistry and Immunology segments constitute more than 80% of the total diagnostics market.
Our Niche
We position ourselves as the manufacturing arm and first choice partner with a ‘Make in India’ initiative for all non-manufacturing companies in India and the sub-continent.
We offer an unmatched development lead time taking only 4 weeks to develop a customized product for our customers based on our in-depth knowledge of R&D, manufacturing and quality systems.
With a manufacturing capacity of 1.5 million litres of reagents per annum, we are the youngest and one of the largest manufacturers of Hematology Reagents in India.
Vanguard Diagnostics also runs its Training Academy. The only diagnostics company offering this service.
Post Market Surveillance twice a year
Accelerated Stability Studies
Real Time Stability Studies
We also have an internal benchmark to resolve quality complaints / queries satisfactorily within 48 hours.
- Post Market Surveillance twice a year
- Accelerated Stability Studies
- Real Time Stability Studies
We also have an internal benchmark to resolve quality complaints / queries satisfactorily within 48 hours.
In depth knowledge of Hematology, Clinical Chemistry and Immunology R&D to develop customized solutions and improve existing ones.
Understanding of the Indian and Global diagnostics needs.
Close association with network of diagnostics distributors in India and world-wide.
Robust sales and marketing acumen.
Contact with IVD companies across the globe.
